- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03149367
Surgical Management of Blepharoptosis
May 10, 2017 updated by: Noha Ali Essameldeen Mohamed Ali, Assiut University
Fixed Versus Adjustable Sutures in Management of Blepheroptosis
Comparison of the results of levator resection operation with the use of fixed sutures technique in which the levator muscle is approached through skin incision and the muscle shortened and sutured directly to the tarsus then the skin crease reformed with interrupted sutures which pick up the underlying levator muscle versus the results with the use of adjustable sutures in which the suture passes through the levator muscle into the tarsal plate and out through the skin edge .the
skin crease is formed separately so that adjusting the suture doesn't open the wound, the suture can be adjusted according to the result up to 4 days post operative.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assuit, Egypt, 71515
- Assuit University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- Cases of blepharoptosis admitted at Assiut University Hospital.
- Cases that are fit for surgery.
Exclusion criteria:
- Cases not fit for surgery.
- Cases of pseudoptosis may result from many conditions that simulate an asymmetry of the upper eyelid level. Dysthyroid ophthalmopathy, enophthalmos, or exophthalmos can accentuate a minimal blepharoptosis or produce the appearance of blepharoptosis on the contralateral normal side,
- Cases with diseases, such as myasthenia gravis; negativity for Bell palsy symptoms; and Marcus Gunn jaw-winking syndrome.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fixed suture
|
The levator muscle is approached through skin incision and the muscle shortened and sutured directly to the tarsus then the skin crease reformed with interrupted sutures which pick up the underlying levator muscle
|
|
Experimental: Adjustable suture
|
The adjustable sutures technique in which the sutures passes through the levator muscle into the tarsal plate and out through the skin edge .the
skin crease is formed separately so that adjusting the suture doesn't open the wound, the suture can be adjusted according to the result up to 4 days post operative.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The cosmetic appearance
Time Frame: One week
|
Symmetry of the two eyelids was calculated based on the difference in the margin reflex distance between them in the primary position of gaze.
The results were classified into good, fair, and poor
|
One week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2017
Primary Completion (Anticipated)
March 1, 2019
Study Completion (Anticipated)
September 1, 2019
Study Registration Dates
First Submitted
May 8, 2017
First Submitted That Met QC Criteria
May 10, 2017
First Posted (Actual)
May 11, 2017
Study Record Updates
Last Update Posted (Actual)
May 11, 2017
Last Update Submitted That Met QC Criteria
May 10, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7540
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blepharoptosis
-
RVL Pharmaceuticals, Inc.CompletedAcquired BlepharoptosisUnited States
-
Levation Pharma, Ltd.Completed
-
Santen Pharmaceutical Co., Ltd.Recruiting
-
Santen Pharmaceutical Co., Ltd.Completed
-
Skelmet IncMassachusetts Eye and Ear InfirmaryCompleted
-
RVL Pharmaceuticals, Inc.CompletedBlepharoptosisUnited States
-
CHU de Quebec-Universite LavalCompleted
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRecruiting
Clinical Trials on levator muscle resection with fixed sutures technique
-
Sohag UniversityNot yet recruitingCongenital PtosisEgypt
-
Minia UniversityNot yet recruitingUpper Eyelid Dynamics
-
Assiut UniversityNot yet recruiting
-
Sahlgrenska University Hospital, SwedenSwedish Cancer FoundationCompleted
-
National Taiwan University HospitalCompleted
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Rabin Medical CenterUnknown
-
Winners ClinicCompletedFace Lift | Suspension Technique | Minimal Invasive SurgeryKorea, Republic of
-
Fundació Institut de Recerca de l'Hospital de la...Carlos III Health Institute; Ministry of Science and Innovation, SpainCompletedProlapse; Female | Prolapse Genital | Prolapse UterovaginalSpain
-
Peking University Third HospitalUnknown